Mon. May 25th, 2026
Spread the love

The Dangote Foundation and Access Bank are collaborating with the Institute of Human Virology, Nigeria (IHVN) to raise N5 billion for the building of a state-of-the-art International Research Centre of Excellence (IRCE) in Abuja, as part of efforts to promote public – private partnership for quality health services, capacity building and research in West Africa.

 

The centre which was established in 2015 is one of the major fulcrums of the vision of IHVN as a local non-governmental and not-for-profit organisation established to bring quality health services within the reach of millions of Nigerians and nationals of the West African region.

 

Speaking at a media briefing in Lagos yesterday, Access Bank Executive Director, Mr. Victor Etuokwu said the ultra-modern research facility by IHVN will go a long way in helping to nip diseases in the bud. According to Etuokwu, Access Bank is not just focused on making profit, but is also a responsible corporate organisation.

 

“The true essence of life is relationship with others. It’s the real reason we are here. When we sit back and watch diseases take over while we do nothing, we stand to lose everything. I think it’s a really worthy cause. So here is a call to you to come, join hands with IHVN and help restore hope. Like we say in our sustainability framework, we are a bank that is not just focused on profit, but also on people and the planet,” Etuokwu said.

 

On his part, the IHVN’s Chief Executive Officer, Dr. Patrick Dakum said the IRCE as a Centre of IHVN would be directed under the leadership of Professor Alash’le G. Abimiku, a distinguished scientist herself, IHVN will use the center to create an enabling environment for creative thinking and innovation in science to address Nigeria’s and global health priorities. He described Access Bank as a worthy partner in the project.

 

“We have a vision as an institute to continue to carry out qualitative research. The institute is expected to provide a platform for the implementation of research and clinical trials of international standards at IHVN as part of global networks; and foster collaborations and synergism between Nigeria’s finest researchers and their counterparts at international research institutions and universities,” he added.

 

Also, the Chairman of the IHVN Ad-hoc Committee for the building of the Center, Alhaji (Dr.) Umaru Mutallab, said with the establishment of IRCE, the Institute foresees a future in which scientists are nurtured and provided world-class infrastructure to research collaboratively on diseases of relevance to the local community such as HIV, TB, malaria, cancer, non-communicable diseases, and emerging infectious diseases.

 

He said that the current drive to eradicate communicable and non-communicable diseases in Nigeria is driven by international donor organisations, which is not sustainable. Similarly, Managing Director/CEO of Dangote Foundation, Zouera Youssoufou, noted that the Foundation was partnering with IHVN as part of its strategic objectives.

 

Initially established in 2004 to address the HIV/AIDS crisis through development of infrastructure for treatment, care, prevention and support for people living with HIV/AIDS, the Institute of Human Virology, Nigeria has had tremendous success in its operations and therefore seeks to continue to fight infectious and non-infectious diseases in Nigeria and the West African sub region through this expansion.

 

By admin

You missed

From Tramadol to Canadian to Exol-5 The New Drug Destroying Nigerian Youths An Investigative Article .From Tramadol to Canadian to Exol-5: The New Drug Destroying Nigerian Youths An Investigative Report on the Shifting Landscape of Substance Abuse in Nigeria Nigeria faces a severe and evolving drug crisis, particularly among its youth. What began with the widespread abuse of Tramadol has progressed through mixtures like “Canadian” to newer pharmaceutical diversions such as Exol-5. This shift reflects deeper issues: easy access to prescription drugs, weak regulation, socioeconomic pressures, and aggressive street-level marketing. NDLEA operations and health studies reveal a public health emergency that threatens an entire generation. Phase 1: The Tramadol Epidemic (2010s–Early 2020s) Tramadol, a synthetic opioid prescribed for moderate to severe pain, became Nigeria’s most notorious street drug. Cheap, potent, and widely smuggled (often from India and other Asian countries), it offered users energy, euphoria, and pain relief — appealing to commercial drivers, laborers, students, and young men seeking confidence or stamina. Scale of the Problem: Millions of tablets seized annually by NDLEA. High prevalence among young males aged 15–35. Linked to increased crime, sexual violence, organ damage (kidney failure, seizures), and mental health breakdowns. Contributed to broader opioid misuse alongside codeine cough syrups. Government responses included tighter import controls and public awareness campaigns, but these only displaced demand to other substances rather than eliminating it. Phase 2: The Rise of “Canadian” (Mid-2020s) “Canadian” or “Canadian Loud” emerged as a popular code for high-grade cannabis (often indica-dominant strains) or cannabis mixed with other synthetics. It gained traction as users sought alternatives or combinations to Tramadol’s effects. This phase marked a move toward imported or locally cultivated premium weed, sometimes laced with stronger chemicals. Youths in urban centers like Lagos, Kano, Jos, and Onitsha embraced it for its perceived “cleaner” high compared to opioids. However, it fueled polydrug use — combining cannabis with opioids, sedatives, or alcohol — amplifying health risks. Phase 3: Exol-5 – The Current Threat (2024–2026) Exol-5 (Benzhexol Hydrochloride / Trihexyphenidyl 5mg), originally a prescription medication for Parkinson’s disease and drug-induced movement disorders, has become the latest pharmaceutical being heavily abused. Why Exol-5? Euphoric Effects: Users report intense euphoria, hallucinations, and a sense of detachment — making it attractive as a cheap “upper” or escape. Accessibility: Sold over-the-counter or on the black market despite being a controlled prescription drug. NDLEA has seized millions of pills in single operations (e.g., 3.1 million pills in Kano in late 2024, and over 5.6 million combined with Tramadol in other busts). Street Names: Exol, Artane, Benzhexol, “Farin Mallam” (in Northern Nigeria). Demographics: Prevalent among youths, laborers, and even psychiatric patients who divert prescriptions. Studies show abuse rates as high as 25% among certain outpatient groups. Health Consequences: Anticholinergic toxicity: Confusion, dry mouth, blurred vision, urinary retention, constipation, and in high doses — delirium, psychosis, seizures, and heart issues. Long-term: Cognitive impairment, addiction, exacerbated mental health disorders. Often mixed with Tramadol, codeine, or cannabis, creating dangerous synergies. In cities like Jos, Exol-5 sits alongside diazepam, Rohypnol, and Tramadol on street markets, easily available to teenagers and young adults. Why This Evolution Continues Supply-Side Failures: Porous borders, corrupt officials, and overproduction of pharmaceuticals enable diversion. Demand Drivers: Unemployment, poverty, peer pressure, trauma, and the pursuit of performance enhancement (e.g., for “hustle” culture). Weak Regulation: Many pharmacies sell restricted drugs without prescriptions. Online and street vendors fill gaps. Displacement Effect: Cracking down on one substance (Tramadol/codeine) pushes users and dealers toward the next available option. NDLEA reports ongoing large seizures, but the problem persists due to high profitability and low risk for mid-level distributors. Broader Impacts on Nigerian Youths Education: Increased dropout rates and poor academic performance. Mental Health: Rising cases of psychosis and depression. Economy: Lost productivity among the working-age population. Crime and Violence: Drug-fueled robberies, cultism, and family breakdowns. Public Health System Strain: Overburdened hospitals treating overdoses and chronic complications. Young people aged 15–39 remain the hardest hit, with national surveys showing drug use prevalence significantly above global averages. What Must Be Done Stronger Enforcement: Consistent prosecution of corrupt enablers and large-scale traffickers. Regulation: Crackdown on rogue pharmacies and better tracking of prescription drugs. Prevention & Rehabilitation: School programs, community outreach, and expanded treatment centers (currently woefully inadequate). Economic Alternatives: Address root causes like youth unemployment. Public Awareness: Honest campaigns highlighting real dangers of “Exol-5” and similar drugs. Conclusion From Tramadol’s opioid grip to “Canadian” cannabis culture and now Exol-5’s anticholinergic highs, Nigeria’s drug crisis is mutating faster than responses can contain it. Exol-5 represents the dangerous new frontier — a legitimate medicine turned youth destroyer due to misuse and greed. Without urgent, multi-layered intervention — combining supply disruption, demand reduction, and socioeconomic support — an entire generation risks being lost to addiction. The time for half-measures is over. Nigeria’s future depends on winning this fight.